1. FRI0488 Analysis of REAL Life Vasoactive Therapy in over 3000 Patients with Systemic Sclerosis (SSC) Reveals Considerable Undertreatment and Significant Changes of Treatment Practice since 2004. (10th June 2014) Authors: Moinzadeh, P.; Elisabeth, A.; Blank, N.; Distler, J.; Fierlbeck, G.; Genth, E.; Guenther, C.; Hein, R.; Henes, J.; Hellmich, M.; Herrgott, I.; Koetter, I.; Kreuter, A.; Krieg, T.; Melchers, I.; Mensing, H.; Mueller-Ladner, U.; Pfeiffer, C.; Riemekasten, G.; Sárdy, M. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long‐term (6 and 12 months) follow‐up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF‐200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. (25th March 2013) Authors: Dirschka, T.; Radny, P.; Dominicus, R.; Mensing, H.; Brüning, H.; Jenne, L.; Karl, L.; Sebastian, M.; Oster‐Schmidt, C.; Klövekorn, W.; Reinhold, U.; Tanner, M.; Gröne, D.; Deichmann, M.; Simon, M.; Hübinger, F.; Hofbauer, G.; Krähn‐Senftleben, G.; Borrosch, F.; Reich, K. Journal: British journal of dermatology Issue: Volume 168:Number 4(2013:Apr.) Page Start: 825 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0209 The Risk for Initial Digital Ulcer Involvement in SSC Patients Decreases with Disease Duration Since the Beginning of Raynaud Phenomenon. (23rd January 2014) Authors: Moinzadeh, P.; Hunzelmann, N.; Mueller-Ladner, U.; Meier, F.; Riemekasten, G.; Becker, M.; Kreuter, A.; Wozel, G.; Melchers, I.; Sardy, M.; Herrgott, I.; Graefenstein, K.; Fierlbeck, G.; Pfeiffer, C.; Worm, M.; Burkhardt, H.; Mensing, H.; Kuhr, K.; Sunderkoetter, C.; Krieg, T. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A651 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0440 New Data on Renal Crisis and Predictive Markers from More Than 3000 Patients. (9th June 2015) Authors: Moinzadeh, P.; Riemekasten, G.; Fierlbeck, G.; Henes, J.; Blank, N.; Melchers, I.; Mueller-Ladner, U.; Kreuter, A.; Susok, L.; Guenther, C.; Zeidler, G.; Pfeiffer, C.; Worm, M.; Aberer, E.; Genth, E.; Distler, J.H.; Hein, R.; Sárdy, M.; Mensing, H.; Koetter, I. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 819 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase‐1 antibodies. (1st June 2016) Authors: Hunzelmann, N.; Riemekasten, G.; Becker, M.O.; Moinzadeh, P.; Kreuter, A.; Melchers, I.; Mueller‐Ladner, U.; Meier, F.; Worm, M.; Lee, H.; Herrgott, I.; Pfeiffer, C.; Fierlbeck, G.; Henes, J.; Juche, A.; Zeidler, G.; Mensing, H.; Günther, C.; Sárdy, M.; Burkhardt, H. Journal: British journal of dermatology Issue: Volume 174:Number 6(2016) Page Start: 1384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase‐1 antibodies. (20th March 2016) Authors: Hunzelmann, N.; Riemekasten, G.; Becker, M.O.; Moinzadeh, P.; Kreuter, A.; Melchers, I.; Mueller‐Ladner, U.; Meier, F.; Worm, M.; Lee, H.; Herrgott, I.; Pfeiffer, C.; Fierlbeck, G.; Henes, J.; Juche, A.; Zeidler, G.; Mensing, H.; Günther, C.; Sárdy, M.; Burkhardt, H. Journal: British journal of dermatology Issue: Volume 174:Number 6(2016) Page Start: 1384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗